CN1096457A - Milk-spitting preventing tablet for baby - Google Patents
Milk-spitting preventing tablet for baby Download PDFInfo
- Publication number
- CN1096457A CN1096457A CN 94103370 CN94103370A CN1096457A CN 1096457 A CN1096457 A CN 1096457A CN 94103370 CN94103370 CN 94103370 CN 94103370 A CN94103370 A CN 94103370A CN 1096457 A CN1096457 A CN 1096457A
- Authority
- CN
- China
- Prior art keywords
- baby
- milk
- spitting
- tablet
- vitamin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000008267 milk Substances 0.000 claims abstract description 7
- 210000004080 milk Anatomy 0.000 claims abstract description 7
- 235000013336 milk Nutrition 0.000 claims abstract description 7
- 108091005804 Peptidases Proteins 0.000 claims abstract description 6
- 102000035195 Peptidases Human genes 0.000 claims abstract description 6
- 238000000034 method Methods 0.000 claims abstract description 5
- 238000002360 preparation method Methods 0.000 claims abstract description 5
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims abstract description 4
- 239000001856 Ethyl cellulose Substances 0.000 claims abstract description 4
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims abstract description 4
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims abstract description 4
- 229930003316 Vitamin D Natural products 0.000 claims abstract description 4
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims abstract description 4
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 claims abstract description 4
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims abstract description 4
- 239000004227 calcium gluconate Substances 0.000 claims abstract description 4
- 229960004494 calcium gluconate Drugs 0.000 claims abstract description 4
- 235000013927 calcium gluconate Nutrition 0.000 claims abstract description 4
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 claims abstract description 4
- 235000019325 ethyl cellulose Nutrition 0.000 claims abstract description 4
- 229920001249 ethyl cellulose Polymers 0.000 claims abstract description 4
- 235000019155 vitamin A Nutrition 0.000 claims abstract description 4
- 239000011719 vitamin A Substances 0.000 claims abstract description 4
- 235000019166 vitamin D Nutrition 0.000 claims abstract description 4
- 239000011710 vitamin D Substances 0.000 claims abstract description 4
- 150000003710 vitamin D derivatives Chemical class 0.000 claims abstract description 4
- 229940045997 vitamin a Drugs 0.000 claims abstract description 4
- 229940046008 vitamin d Drugs 0.000 claims abstract description 4
- 235000011478 zinc gluconate Nutrition 0.000 claims abstract description 4
- 239000011670 zinc gluconate Substances 0.000 claims abstract description 4
- 229960000306 zinc gluconate Drugs 0.000 claims abstract description 4
- 230000001954 sterilising effect Effects 0.000 claims abstract description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims abstract description 3
- 108090000284 Pepsin A Proteins 0.000 claims description 6
- 102000057297 Pepsin A Human genes 0.000 claims description 6
- 229940111202 pepsin Drugs 0.000 claims description 6
- 108090000746 Chymosin Proteins 0.000 claims description 3
- 102000004142 Trypsin Human genes 0.000 claims description 3
- 108090000631 Trypsin Proteins 0.000 claims description 3
- 229940080701 chymosin Drugs 0.000 claims description 3
- GNOLWGAJQVLBSM-UHFFFAOYSA-N n,n,5,7-tetramethyl-1,2,3,4-tetrahydronaphthalen-1-amine Chemical compound C1=C(C)C=C2C(N(C)C)CCCC2=C1C GNOLWGAJQVLBSM-UHFFFAOYSA-N 0.000 claims description 3
- 210000000496 pancreas Anatomy 0.000 claims description 3
- 239000012588 trypsin Substances 0.000 claims description 2
- 229960001322 trypsin Drugs 0.000 claims description 2
- 230000002265 prevention Effects 0.000 claims 2
- 210000004916 vomit Anatomy 0.000 claims 2
- 230000008673 vomiting Effects 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 1
- 239000007952 growth promoter Substances 0.000 abstract description 2
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 239000011573 trace mineral Substances 0.000 abstract description 2
- 235000013619 trace mineral Nutrition 0.000 abstract description 2
- 229940088594 vitamin Drugs 0.000 abstract description 2
- 229930003231 vitamin Natural products 0.000 abstract description 2
- 239000011782 vitamin Substances 0.000 abstract description 2
- 235000013343 vitamin Nutrition 0.000 abstract description 2
- 150000003722 vitamin derivatives Chemical class 0.000 abstract description 2
- 239000002775 capsule Substances 0.000 abstract 1
- 229960004106 citric acid Drugs 0.000 abstract 1
- 235000015165 citric acid Nutrition 0.000 abstract 1
- 229960004667 ethyl cellulose Drugs 0.000 abstract 1
- 231100000957 no side effect Toxicity 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
The present invention relates to a kind of tablet and manufacture method thereof of the baby's of preventing spitting milk, belong to technical field of living necessaries of humans.Milk-spitting preventing tablet for baby becomes to be grouped into by proteolytic enzyme, calcium gluconate, vitamin A, zinc gluconate, ethyl cellulose, citric acid and vitamin D etc. are multiple, after fully mixing with certain proportion, with r roentgenization sterilization, at last under aseptic condition with the tablet machine tabletting or make capsule.This product is pure biological preparation, and the baby is had no side effect, and can also replenish necessary vitamin of baby and trace element simultaneously, helps baby's growth promoter.
Description
The present invention relates to a kind of tablet and manufacture method thereof of the baby's of preventing spitting milk, belong to technical field of living necessaries of humans.
The phenomenon of baby's very easy generation spitting milk after sucking, wherein particularly outstanding with baby's performance of 0~6 month, severe patient will influence baby's normal development and health.Generally can only adopt the back of breast-feeding clap to embrace ways such as baby 20 minutes at present, not only being not easy to be accepted by most mother, and effect ideal also and not really.So far do not see as yet about preventing the research report of spitting milk preparation after baby's suckling.
The objective of the invention is: utilize the proteolytic enzyme can hydrolysis and the characteristics of solidifying protein, by add the generation that this fermentoid prevents spitting milk phenomenon behind the infant feeding to the baby.This product is pure biological preparation, and is without any side effects to the baby, can also replenish necessary vitamin of baby and trace element simultaneously, helps baby's growth promoter.
Content of the present invention is that milk-spitting preventing tablet for baby is made up of by following prescription following various components:
Proteolytic enzyme: 5~30mg ethyl cellulose: 0.5~2.0mg
Calcium gluconate: 1.0~5.0mg citric acid: 1.0~5.0mg
Vitamin A: 0.1~0.6mg vitamin D: 0.005mg
Zinc gluconate: 0.05~0.15mg
Proteolytic enzyme wherein can be any in trypsin, pepsin, Chymosin or pancreas and the pepsin.
The preparation method of milk-spitting preventing tablet for baby is that in i.e. 0 ℃~25 ℃ fully mixing down of low temperature, with the sterilization of r roentgenization, x ray irradiation x dosage is 10 with above-mentioned each component (solid)
4~10
6La Te (Rad) uses tablet machine tabletting or capsulation at last under aseptic condition.
Embodiments of the invention are:
1 | 2 | 3 | 4 | ||
Component | Protease | Trypsin 30.0 | Pepsin 20.0 | Chymosin 10.0 | Pancreas+pepsin 3.0+5.0 |
Ethyl cellulose | 2.0 | 1.5 | 0.5 | 1.0 | |
Calcium gluconate | 2.0 | 5.0 | 4.0 | 3.0 | |
Zinc gluconate | 0.15 | 0.05 | 0.10 | 0.10 | |
Vitamin A | 0.2 | 0.6 | 0.3 | 0.4 | |
Vitamin D | 0.005 | 0.005 | 0.005 | 0.005 | |
Citric acid | 4.0 | 3.0 | 5.0 | 2.0 | |
Process conditions | Temperature (℃) | 5 | 10 | 15 | 25 |
Radiant intensity (Rad) | 10 4 | 10 5 | 10 6 | 10 5 |
Annotate: the unit of data is milligrams in the table.
Claims (3)
1, a kind of milk-spitting preventing tablet for baby is characterized in that the composed as follows of vomit milk prevention sheet:
Proteolytic enzyme: 5~30mg ethyl cellulose: 0.5~2.0mg
Calcium gluconate: 1.0~5.0mg citric acid: 1.0~5.0mg
Vitamin A: 0.1~0.6mg vitamin D: 0.005mg
Zinc gluconate: 0.05~0.15mg
2, vomit milk prevention sheet as claimed in claim 1 is characterized in that wherein said proteolytic enzyme is to be selected from any in trypsin, pepsin, Chymosin or pancreas and the pepsin.
3, a kind of preparation has the method for the milk-spitting preventing tablet for baby of composition according to claim 1, it is characterized in that this method is: each component is fully mixed down at 0 ℃~25 ℃ in proportion, and with the sterilization of r roentgenization, irradiation dose is 10
4~10
6La Te uses tablet machine tabletting or capsulation at last under aseptic condition.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 94103370 CN1096457A (en) | 1994-04-01 | 1994-04-01 | Milk-spitting preventing tablet for baby |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 94103370 CN1096457A (en) | 1994-04-01 | 1994-04-01 | Milk-spitting preventing tablet for baby |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1096457A true CN1096457A (en) | 1994-12-21 |
Family
ID=5031028
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 94103370 Pending CN1096457A (en) | 1994-04-01 | 1994-04-01 | Milk-spitting preventing tablet for baby |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1096457A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7235390B2 (en) * | 2001-11-20 | 2007-06-26 | Health Education Corporation | Nutrient absorption enhancing compositions and methods |
US20140369996A1 (en) * | 2006-11-30 | 2014-12-18 | Nutrichym As | Chymosin for the Prevention and Treatment of Gastrointestinal Disorders |
CN106306887A (en) * | 2016-08-19 | 2017-01-11 | 朱路 | Plant vitamin drops capable of relieving infantile puking discomfort |
-
1994
- 1994-04-01 CN CN 94103370 patent/CN1096457A/en active Pending
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7235390B2 (en) * | 2001-11-20 | 2007-06-26 | Health Education Corporation | Nutrient absorption enhancing compositions and methods |
US20140369996A1 (en) * | 2006-11-30 | 2014-12-18 | Nutrichym As | Chymosin for the Prevention and Treatment of Gastrointestinal Disorders |
CN106306887A (en) * | 2016-08-19 | 2017-01-11 | 朱路 | Plant vitamin drops capable of relieving infantile puking discomfort |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0675689B1 (en) | Medical foods for the nutritional support of child/adult metabolic diseases | |
Meyer | Breast Feeding in the United States: Extent and Possible Trend: A Survey of 1,904 Hospitals with Two and a Quarter Million Births in 1956 | |
CN1748571A (en) | Calcium supplementing health food base materials | |
CN1096457A (en) | Milk-spitting preventing tablet for baby | |
CN1195544C (en) | Liver function ameliorating agents | |
CN104687054A (en) | Nanoscale calcium health food and preparation method thereof | |
US6235719B1 (en) | Uses of compositions with α-lactalbumin base | |
CN1115620A (en) | Drinking water for infant | |
CN1336127A (en) | Prepn. and use of enzymolyzed buckwheat protein product | |
CN110269099B (en) | Composition of multiple pH buffer formula and protein digestive aid and application thereof | |
CN105410895A (en) | Calcium supplementing composition and preparation thereof | |
CN105767997A (en) | Bee pollen and preparation method thereof | |
CA1315677C (en) | Use of epidermal growth factor | |
CN1203878C (en) | Organic state micro element supplement agent | |
CN101091720A (en) | Health food with efficacy for preventing osteoporosis and preparation method | |
JPH04365444A (en) | Antiallergic formulated milk | |
CN1072444C (en) | Health-care milk and production method therefor | |
Fidler et al. | The role of doctors in influencing infant feeding practices in South India | |
CN114176219B (en) | Hypoallergenic milk protein partial hydrolysis formula food and preparation method thereof | |
Sandstead | Improving study design | |
Karimi et al. | Prophylactic effect of recombinant factor VIIa with congenital factor VII deficiency | |
Buckley | Some new and important clues to the causes of colic | |
CN101375859A (en) | Compound composite medicament for preventing and treating iron-deficiency anemia and secondary infection of young stock | |
CN1200242A (en) | Health-care milk and method for preparing same | |
Todd | Dairy products in infant nutrition-latest developments |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C01 | Deemed withdrawal of patent application (patent law 1993) | ||
WD01 | Invention patent application deemed withdrawn after publication |